"NHS England Halts Puberty Blockers for Transgender Youth Amid Controversy"

England's NHS has halted the use of puberty blockers for transgender minors due to insufficient evidence of safety and effectiveness, pending a study to be conducted by December. While less than 100 young people in England are currently prescribed puberty blockers and will be able to continue their treatments, clinicians can still apply for the treatment under NHS England's Individual Funding Request process. The decision has sparked debate over the risks and benefits of gender-affirming care, with major medical associations in the U.S. emphasizing its safety and effectiveness, while some states have restricted gender-affirming care for transgender youth.